Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?

From Yahoo Finance: 2025-05-10 04:17:00

Investors are increasingly drawn to dividend-paying stocks for long-term market success. Ned Davis Research states that over 80% of companies pay dividends, with a yield-based strategy outperforming dividend growers since 1973. Analysts recommend examining a stock’s dividend yield for investment decisions. Pfizer Inc. (NYSE: PFE) ranks high among high-yield dividend stocks.

Pfizer Inc. (NYSE: PFE) is a multinational pharmaceutical company focusing on oncology growth. The company’s oncology revenue surged by 25% in 2024, showcasing its success. Despite mixed Q1 earnings in 2025, Pfizer remains committed to its dividend growth, returning $2.4 billion to investors. With a 15-year track record of dividend growth, Pfizer stands out among high-yield stocks.

Pfizer Inc. (NYSE: PFE) holds the top spot on the list of best high-yield dividend stocks. While PFE shows promise, some deeply undervalued dividend stocks may offer higher returns. Investors seeking a promising dividend stock with strong growth potential should explore other opportunities. Check out Insider Monkey’s report on deeply undervalued dividend stocks for more information.

Read more: Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?